Antibody titres before and after a third dose of the SARS-CoV-2 BNT162b2 vaccine in patients with cancer

被引:29
作者
Debie, Yana [1 ,2 ,3 ]
Vandamme, Timon [1 ,2 ,3 ]
Goossens, Maria E. [4 ]
van Dam, Peter A. [1 ,2 ,3 ]
Peeters, Marc [2 ,3 ]
机构
[1] Antwerp Univ Hosp, Multidisciplinary Oncol Ctr Antwerp MOCA, Drie Eikenstr 655, B-2650 Edegem, Belgium
[2] Univ Antwerp, Integrated Personalized & Precis Oncol Network IP, Ctr Oncol Res CORE, B-2650 Edegem, Belgium
[3] Antwerp Univ Hosp, Drie Eikenstr 655, B-2650 Edegem, Belgium
[4] Sciensano, Observat Clin Trials, SD Infect Dis Humans, Rue Juliette Wytsmanstr 14, B-1050 Brussels, Belgium
关键词
D O I
10.1016/j.ejca.2021.12.025
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:177 / 179
页数:3
相关论文
共 10 条
[1]   Presence of specific T cell response after SARS-CoV-2 vaccination in rheumatoid arthritis patients receiving rituximab [J].
Benucci, Maurizio ;
Damiani, Arianna ;
Infantino, Maria ;
Manfredi, Mariangela ;
Grossi, Valentina ;
Lari, Barbara ;
Gobbi, Francesca Li ;
Sarzi-Puttini, Piercarlo .
IMMUNOLOGIC RESEARCH, 2021, 69 (04) :309-311
[2]   Evidence of SARS-CoV-2-Specific Memory B Cells Six Months After Vaccination With the BNT162b2 mRNA Vaccine [J].
Ciabattini, Annalisa ;
Pastore, Gabiria ;
Fiorino, Fabio ;
Polvere, Jacopo ;
Lucchesi, Simone ;
Pettini, Elena ;
Auddino, Stefano ;
Rancan, Ilaria ;
Durante, Miriam ;
Miscia, Michele ;
Rossetti, Barbara ;
Fabbiani, Massimiliano ;
Montagnani, Francesca ;
Medaglini, Donata .
FRONTIERS IN IMMUNOLOGY, 2021, 12
[3]  
Eliakim-Raz N, JAMA-J AM MED ASSOC, V326, P2203
[4]  
Gounant V, 2021, J THORAC ONCOL OFF P
[5]   Three Doses of an mRNA Covid-19 Vaccine in Solid-Organ Transplant Recipients [J].
Kamar, Nassim ;
Abravanel, Florence ;
Marion, Olivier ;
Couat, Chloe ;
Izopet, Jacques ;
Del Bello, Arnaud .
NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (07) :661-662
[6]  
Levin EG, NEW ENGL J MED, V385, P84
[7]   Reduced humoral immune response after BNT162b2 coronavirus disease 2019 messenger RNA vaccination in cancer patients under antineoplastic treatment [J].
Peeters, M. ;
Verbruggeny, L. ;
Teuwen, L. ;
Vanhoutte, G. ;
Vande Kerckhove, S. ;
Peeters, B. ;
Raats, S. ;
Van der Massen, I. ;
De Keersmaecker, S. ;
Debie, Y. ;
Huizing, M. ;
Pannus, P. ;
Neven, K. ;
Arien, K. K. ;
Martens, G. A. ;
Van den Bulcke, M. ;
Roelant, E. ;
Desombere, I. ;
Anguille, S. ;
Goossens, M. ;
Vandamme, T. ;
van Dam, P. .
ESMO OPEN, 2021, 6 (05)
[8]  
Rottenberg Y, 2021, JAMA ONCOL, V2021, P6764
[9]   Immune responses to two and three doses of the BNT162b2 mRNA vaccine in adults with solid tumors [J].
Shroff, Rachna T. ;
Chalasani, Pavani ;
Wei, Ran ;
Pennington, Daniel ;
Quirk, Grace ;
Schoenle, Marta, V ;
Peyton, Kameron L. ;
Uhrlaub, Jennifer L. ;
Ripperger, Tyler J. ;
Jergovic, Mladen ;
Dalgai, Shelby ;
Wolf, Alexander ;
Whitmer, Rebecca ;
Hammad, Hytham ;
Carrier, Amy ;
Scott, Aaron J. ;
Nikolich-Zugich, Janko ;
Worobey, Michael ;
Sprissler, Ryan ;
Dake, Michael ;
LaFleur, Bonnie J. ;
Bhattacharya, Deepta .
NATURE MEDICINE, 2021, 27 (11) :2002-+
[10]   Immunoglobin G/total antibody testing for SARS-CoV-2: A prospective cohort study of ambulatory patients and health care workers in two Belgian oncology units comparing three commercial tests [J].
van Dam, Peter ;
Huizing, Manon ;
Roelant, Ella ;
Hotterbeekx, An ;
De Winter, Fien H. R. ;
Kumar-Singh, Samir ;
Moons, Pieter ;
Amajoud, Zainab ;
Vulsteke, Christof ;
Croes, Lieselot ;
Janssens, Annelies ;
Berneman, Zwi ;
Prenen, Hans ;
Meuris, Leander ;
Vanden Berghe, Wim ;
Smits, Evelien ;
Peeters, Marc .
EUROPEAN JOURNAL OF CANCER, 2021, 148 :328-339